Thursday, 3rd November Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Chairs/facilitators: James Bond, Gail Garvey, Daniel Lindsay, Bena Brown, Rachael Jaenke

Description:

This session invites First Nations people with a lived experience of cancer, their families and interested health professionals, cancer researchers and policymakers involved in their care, to participate in a focused discussion to brainstorm and identify solutions for achieving the cancer survivorship priorities of this group. This session will report on the initial results of a First Nations Survivorship Delphi study to identify cancer survivorship priorities, and how important and achievable those priorities are. Identified barriers to achieving survivorship priorities will be reported, and potential solutions to these barriers prioritised during this session.

This breakfast session will be a facilitated discussion around the care of the older person with head and neck cancer, designed to engage the audience about the considerations, challenges and opportunities to improve interdisciplinary care in relation to the older person with cancer who has multiple comorbidities and is taking multiple medications.

Panellists:

• Dr Ruth Hubbard, Consultant Geriatrician, Princess Alexandra Hospital, Brisbane
• Dr Michael Krasovitsky, Medical Oncologist, The Kinghorn Centre, Sydney
• Justine Leach, Nurse Unit Manager, North Lakes Cancer Centre, Royal Brisbane and Women’s Hospital
• Dr Lachlan McDowell, Radiation Oncologist, Princess Alexandra Hospital, Brisbane
• Dr Andrew Pastuszcek, ENT Surgeon, Toowoomba Base Hospital and St Andrew's Hospital, Toowoomba
• Jean Nel, Senior Physiotherapist and GeriOnc Allied Health Professional, Caboolture Hospital

This breakfast session is sponsored by AstraZeneca and delivered by the COSA Geriatric Oncology Group

Time: 7:00am - 8:45am
Date: 3 November 2022

Agenda:

• Decisions and dilemmas in dMMR advanced/recurrent EC management, Professor Linda Mileshkin Medical Oncologist and Director of Medical Oncology - Peter MacCallum Cancer Centre, VIC
• Nursing Considerations for the future treatment of Endometrial Cancers, Anne Mellon Clinical Nurse Consultant Gynaecological Oncology - Hunter New England Centre, NSW
• Q&A Discussion

Jemperli is indicated as monotherapy for the treatment of adult patients with recurrent or advanced mismatch repair deficient (dMMR) endometrial cancer (EC) that has progressed on or following prior treatment with a platinum-containing regimen. For product information please visit www.gsk.com.au/jemperli 

Time: 7:00am - 8:45am
Date: 3 November 2022

Description: The multidisciplinary management of patients with advanced cutaneous squamous cell carcinoma (CSCC) is entering a new era. The symposium aims to provide delegates with an understanding and an appreciation of the contemporary management of patients with advanced CSCC in regional and rural Australia.
The symposium will feature the perspectives and real-world clinical experiences from a medical oncology, radiation oncology and surgical point of view. Delegates will have an opportunity to interact with the panel during the symposia to further their understanding in advanced CSCC management.

Speakers:

• Prof. Rahul Ladwa. Medical Oncologist. Princess Alexandra Hospital, Brisbane, QLD
• Prof. Gerald Fogarty. Radiation Oncologist. Icon Cancer Centre, Revesby, NSW
• Prof. Sandra Krishnan. Breast Surgical Oncologist and General Surgeon. Sydney Adventist Hospital, Wahroonga, NSW
• Prof. Rob Zielinski. Central West Cancer Care Centre, Orange, NSW

• Indigenous Māori experience of cancer in Aotearoa New Zealand - Sue Crengle
• Putting co-designed lung cancer screening into practice - Kwun Fong
• Financial costs for First Nations Australians diagnosed with cancer in Queensland, Australia - Daniel Lindsay
• First Nations Health Equity Strategy - Making tracks together: Queensland's Aboriginal and Torres Strait Islander health equity framework - Wendy Ah Chin

• Treatment of cancer-related malnutrition: providing optimal care for all - Emily Jeffrey
• Lung cancer, swallowing and voice: The role of Speech Pathology - Jacqui Frowen
• Is there a role for medicinal cannabis in symptom management? - Janet Hardy
• Breathlessness - To Be Confirmed

Chair: John Bashford

• Medical Perspective  - Jermaine Coward
• Site Perspective  - Sophie Mepham
• Patient Perspective   - Diane Sheehan
• Legal Perspective  - David Shannon

Followed by panel discussion

• Introducing the ADAPT CP, engaging services, staff and preparing to implement new processes. - Heather L Shepherd
• The role of online resources to support patients and health professionals, how well used or useful are they? - Joanne M Shaw
• How the implementation of the ADAPT Clinical Pathway played out for staff, services and patients - Mona Faris
• Adherence to a clinical pathway for anxiety and depression in cancer patients in routine care; impact of core versus enhanced implementation strategies. - Phyllis N Butow

Followed by Panel Discussion

• Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP): a randomized networked teletrial - Kate Burbury
• Equity of opportunity for safe care: Raising awareness of elder abuse in older adults with cancer. - Catherine Devereux
• Attitudes of Australian patients undergoing treatment for upper gastrointestinal cancers to different models of nutrition care delivery: qualitative investigation - Kate Furness
• Support-seeking by cancer caregivers living in rural Australia - Lizzy Johnston
• The ‘Engage’ program: Effective childhood cancer survivorship care - Jordana McLoone
• Improving access to cancer clinical trials for patients from culturally and linguistically diverse (CALD) backgrounds – results of a national survey, part 3 - solutions - Abhijit Pal

• Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series - Wei-Sen Lam
• Identifying areas of improvement in the clinical care of early stage lung cancer patients: discordance of clinical and pathological staging and timeliness of care - Jacqueline Bentel
• The impact of the early COVID-19 pandemic on time to presentation and diagnosis of lung cancer - Rebecca J Bergin
• Exercise across the lung cancer care continuum: an overview of systematic reviews - Lara Edbrooke
• Tepotinib + gefitinib in patients with EGFR-mutant NSCLC with MET amplification: final analysis of INSIGHT - Malinda Itchins
• Australian lung cancer survivors’ experiences of novel treatments and healthcare: Ongoing physical and psychological needs - Nicole Rankin

Panellists:

A/Prof Dion Forstner, Radiation Oncologist, President-Elect COSA

Professor Gail Garvey, Professor in Indigenous Health Research, The University of Queensland

Ms Deborah Henderson, Cancer Care Consumer

Professor Michael Kidd AM, Deputy Chief Medical Officer/Principal Medical Advisor, Australian Government

Ms Tania Rishniw, Deputy Secretary Primary and Community Care, Department of Health and Aged Care

• Shaping the future of cancer control – the Australian Cancer Plan - Dorothy Keefe

Join the conversation using Slido! Go to Slido.com and enter the event code #COSA-ACP, or scan the QR code with your phone or tablet.

• Development of psycho-oncology telehealth recommendations: a Delphi consensus study - Claire Cooper
• Dietary counselling to increase soluble fibre in patients with gynaecological cancers undergoing pelvic radiotherapy: a feasibility study - Emilie Croisier
• Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial - Daphne Day
• Exploring treatment options for primary cutaneous CD4+ small/ medium T-cell lymphoproliferative disorder (PCSMLPD) – with particular focus on ultra-low dose radiotherapy - Jennifer Ward
• Feasibility of DPYD Genotype-guided personalised Fluoropyrimidine dosing - Cass White
• Neoadjuvant chemoradiotherapy or peri-operative chemotherapy, which is superior in gastroesophageal adenocarcinoma? - A retrospective analysis. - Zachary Wilson
• Retrospective case series on rural and regional experience of neuroendocrine tumour (NET) management in Illawarra Shoalhaven Local Health District (ISLHD) between 2015-2020 - Danka Zebic
• DPYD Genotype-guided personalised Fluoropyrimidine dosing: determining the barriers and Enablers of implementation - Cass White
• Clinicians' perspectives on lung cancer referral pathway in a regional health service - Zulfiquer Otty
• Financial toxicity in patients with cancer attending a public Australian tertiary hospital – a qualitative analysis. - Thivagar Yogaparan
• Developing a person-centred bereavement care service for health professionals working with diverse communities - Nicci Bartley
• Stakeholders’ perspectives on how telephone cancer information and support services (CISS) create social value for Australian society. - Jessica Bucholc
• Nutritional status of patients undergoing Chimeric Antigen Receptor T-Cell (CAR-T) therapy; a feasibility study. - Danika Carty
• Rate of menstruation history taking and counselling before, during and after anticancer treatments - Joshua Hurwitz
• Rates of fertility discussions and counselling before, during and after anticancer treatments: women deserve gender specific care - Joshua Hurwitz
• Rates of sexual history taking and sexual dysfunction counselling with cancer care - Joshua Hurwitz
• Enablers and barriers to referral and delivery of multidisciplinary prehabilitation in the Autologous Stem Cell Transplant population: a theory-based interview study. - Lara Edbrooke
• Hanging connections in cancer survivorship care delivered via telehealth: reflections from the Sydney Cancer Survivorship Centre multi-disciplinary team - Haryana M Dhillon
• A qualitative study of factors influencing Advanced Care Planning in oncology - Candice Donnelly
• Measurement that matters: an Australian set of multidisciplinary colorectal cancer quality indicators - Candice Donnelly
• Genetic testing in prostate cancer: a scoping literature review  - Kim Edmunds
• Prescribing rates of Pneumocystis jirovecii pneumonia prophylaxis - Yun Megan Foo
• The PRIMCAT cohort study: analysis of treatment utilisation, costs, and outcomes in Victoria for patients with cancer. - Fanny Franchini
• Implementation of the What Matters 2Adults (WM2A) wellbeing measure into cancer services in New South Wales - Alana Gall
• Delivering supervised group exercise to patients with cancer via telehealth: an implementation study using the RE-AIM framework - Elise M Gane
• Innovation in regional cancer trials workforce development: the TrialHub Fellowship Program - Chloe L Georgiou
• Patient vignettes reflecting the impact of The Australian Rare Cancer Portal on patients with rare cancer - Chloe L Georgiou
• Providing patients with copies of oncology letters - Samuel Harris
• Barriers and enablers of uptake and adherence to digital health interventions in older patients with cancer: A systematic review - Syarafina SH Hasnan
• Implementation of geriatric assessments in cancer care: an umbrella review - Sharon He
• Discussing diet, nutrition, and body weight after treatment for gynaecological cancer: a conversation analytic study of outpatient consultations - Lizzy Johnston
• Exploring clinical documentation and management of cancer patients' Complementary and Alternative Medicine (CAM) - what are we missing? - Ellen Jones
• What factors can influence cancer patients’ Complementary and Alternative Medicine (CAM) use during anti-cancer treatment? - Ellen Jones
• Exploring pattern of Complementary and Alternative Medicine (CAM) use over cancer patients’ course of treatment - Ellen Jones
• e-ENHANCE: co-design of an e-platform to enhance personalised nutrition and physical activity for management of cancer-related malnutrition and muscle loss - Nicole Kiss
• A scoping review of health professional oncosexology education and training programs focused on adolescents and young adults (AYA) - Safeera Hussainy
• Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for older adults with lung cancer - Penny Mackenzie
• A fertile future for cancer patients: and update on improvements on options in Australia. - Andrea Martin
• The ‘Good Life – Cancer Survivorship’ program – implementation of a model of allied health survivorship cancer care within a community health setting - Rebecca McIntosh
• Tackling cancer-related financial toxicity to improve health services and equity - Jordana McLoone
• Differences in cancer clinical trial characteristics between metropolitan and rural trial sites in Victoria, Australia - Narelle McPhee
• Views and experiences of cancer clinical trial participants at a regional cancer centre: a qualitative study   - Narelle McPhee
• Assisted dying the perspective from health services staff - Geraldine McDonald
• Consumer Engagement through a Patient Parliament   - Fiona Mouritz
• Cost-benefit of pre-treatment dihydropyrimidine dehydrogenase genotyping to individualise fluoropyrimidine-based chemotherapy in a contemporary Australian setting. - Hansoo Kim
• Victorian Integrated Cancer Services: advance care planning practices in Victorian cancer services - Linda Nolte
• The impact of COVID-19 on cancer diagnoses in Victoria - Sandra Picken
• Evaluating the feasibility and acceptability of a psychosexual intervention for couples post-allogeneic haematopoietic stem cell transplantation - Brindha Pillay
• Meeting the needs of rural/regional cancer patients in survivorship: understanding age differences in the role of Telehealth - Karina Dr Rune
• Cost estimation of radiotherapy for local control and overall survival benefit of lung cancer - Jesmin Shafiq
• Digitally-delivered models of exercise support for Haematological cancer survivors: a cross-sectional survey study exploring factors associated with likelihood of uptake  - Camille E Short
• Review of utilisation of Oral Chemotherapy Clinic (OCC) to improve quality of care for metastatic breast cancer patients receiving oral anti-cancer agents. - Priyadarshini Sinha
• Effectiveness of a novel cross-sector in-hospital service for parents who are cancer patients and their adolescent and young adult children - Xiomara Skrabal Ross
• Primary prevention of skin cancer in primary care settings – a scoping review - Amelia K Smit
• Professionally-led support groups for people living with advanced cancer: a systematic scoping review of effectiveness and factors critical to implementation success within real-world healthcare settings  - Andrea L Smith
• Cancer malnutrition and sarcopenia: how risky is it? - Belinda Steer
• Audit of clinical practice on monitoring micronutrient status of UGI cancer survivors attending Sydney Cancer Survivorship Clinic (SCSC) - Janette Vardy
• A qualitative study on the experiences of physical activity among women diagnosed with ovarian cancer. - Kellie Toohey
• Genetic counselling and testing - metastatic castrate resistant prostate cancer - Jan Wakeling
• Experiences of healthcare professionals promoting exercise for men with prostate cancer: a qualitative exploration - Jasmine Yee
• Breast Cancer Bundle of care: a pilot study - JULIA M R SCHULZ
• Occupational therapy and physiotherapy in a new cancer-specific palliative unit: A retrospective audit. - Grace Butson
• Shared care using a web-based care plan tool in breast cancer survivorship - Jeremy Chow
• A model of care for the shared management of regionally located patients with neuroendocrine cancer - Chloe McAinch
• Retrospective audit of oncology patients admitted with immunotherapy related adverse events and subsequent outcomes - Arshya Pankaj
• To improve outcomes of patients > 65 years attending the Onco-Geriatric service at St Vincent’s Hospital Melbourne (SVHM) by providing comprehensive, holistic and integrated geriatric care. - Sandra Picken
• Victorian Integrated Cancer Services (VICS) transition to the Victorian data Access Linkage Trust (VALT) - Sandra Picken
• A single centre retrospective study of medically futile treatment and time-appropriate acute resuscitation plan documentation - Prasanth Sekar
• Importance and interest in sexual activity following ovarian, tubal and peritoneal cancer treatment: a mixed-methods study - Alice Sporik
• Implementation of sexual orientation, gender identity and preferred name data collection at Peter MacCallum Cancer Centre   - Antonela Vogranic
• Title: 'Men's health in oncology: a survey of (Australian) senior cancer nurses'. - Michael Whitehead
• Pertuzumab desensitisation; Case Reports - Kate Wright
• Who is caring for the carer? Supporting the wellbeing of cancer carers - Peta Wright
• Incidence of side effects caused by treatment of patients with Prostate Cancer- Experience in a rural cancer centre. - Mihitha Ariyapperuma
• The perception of and access to nutrition services for men with prostate cancer treated with androgen deprivation therapy. - Brenton Baguley
• The effectiveness of combined nutrition and exercise interventions on body weight, lean and fat mass in adults diagnosed with cancer: a systematic review and meta-analysis - Brenton Baguley
• Challenges of a clinical nurse consultant-care coordinator (CNCCC) in a new state wide service  - Monique Blanchard
• Exploring attitudes towards COVID-19 vaccination in adults with haematological malignancies. - Daphne Day
• Rates of contraceptive uptake and documentation of discussion with anticancer therapy: women deserve gender specific care - Joshua Hurwitz
• A minority of women of child bearing potential are tested for pregnancy before chemoimmunotherapy: an Australian Cancer Centre experience - Joshua Hurwitz
• Non-pharmacological self-management strategies for chemotherapy-induced peripheral neuropathy in people with advanced cancer: A systematic review and meta-analysis - Megan Crichton
• Enhancing patient care in radiation oncology - Lorraine Lewis
• Feasibility, acceptability and utility of a pilot nurse-led survivorship program for people with metastatic melanoma (MELCARE) - Haryana Dhillon
• Unmet supportive care needs of people affected by cancer in New South Wales - Annie Miller
• Australian cancer survivors' unmet supportive care needs: a meta-review of what's next? - Carolyn Mazariego
• Knowledge and attitudes toward complementary medicine and cannabis: a survey of health professionals working in a cancer hospital in Australia - Suzanne Grant
• COVID-19 vaccine uptake and hesitancy amongst Australian patients with breast cancer. - Jo Hudson
• Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer - Tamara L Jones
• Acupuncture for treating a symptom cluster (pain, fatigue, sleep, neuropathy) for women with breast cancer: a feasibility study - Judith JL Lacey
• Safe prescribing of Medicinal Cannabis in a comprehensive cancer hospital in NSW - Judith Lacey
• A retrospective evaluation of Oncology Massage on self-reported symptom burden and wellbeing for breast cancer patients at Chris O’Brien Lifehouse.  - Judith Lacey
• The unmet supportive care needs of people affected by cancer during the COVID-19 pandemic: an integrative review - Helen S Legge
• Practical factors that influence physical activity in women living with metastatic breast cancer: a qualitative interview study - Mark Liu
• Perceptions and beliefs around physical activity in women living with metastatic breast cancer: a qualitative interview study - Mark G Liu
• Ballet after breast cancer: Investigating the feasibility, acceptability, and participant experiences of a novel 16-week classical ballet intervention for breast cancer survivors. - Eliza Macdonald
• Evaluating the effect of upper-body morbidity on quality of life after primary breast cancer treatment: a systematic review and meta-analysis - Eliza Macdonald
• Head and neck symptom severity (HNSS) and symptom interference (HNSI), health-related quality of life (HRQL) and emotional distress trajectories during and after chemoradiotherapy (CRT) for HPV-associated oropharyngeal cancer (HPVOPC): a TROG 12.01 secondary analysis - Lachlan McDowell
• Body composition changes in patients with breast cancer pre- to post-exercise program - Leah McIntyre
• Regional and rural clinical trial ambassador program - Anne Woollett
• Slipping through the cracks: identifying opportunities to improve malnutrition and sarcopenia management at a regional oncology unit - Louise Moodie
• Effects of exercise on physical function in adults with haematological cancer: a systematic review and meta-analysis - Kellie Toohey
• Impact of the COVID-19 pandemic on supportive care outcomes of breast cancer survivorship patients in Gippsland, Victoria - Harriet O'Rourke
• Measuring cognitive dysfunction in Glioblastoma (GBM) – an audit of current clinical practice in the use of formal cognitive assessments at Sir Charles Gairdner Hospital​ - Ek Leone Oh
• What are the effects of multimodal prehabilitation interventions in men affected by prostate cancer? A systematic review - Catherine Paterson
• The experiences of supportive care among partners of men diagnosed with prostate cancer: A qualitative systematic review - Catherine Paterson
• What are the unmet supportive care needs of people affected by cancer: An umbrella systematic review - Catherine Paterson
• Prevalence of Fluoropyrimidine-induced Toxicities in Patients receiving Fluoropyrimidine-based Treatment - Michael Powell
• Patient-determined appropriateness of the EORTC QLQ-C30 and QLQ-OV28 for routine PROMs data collection in the National Gynae-Oncology Registry (NGOR): A thematic analysis of the perspectives and content needs of women with ovarian cancer. - Sharnel Perera
• CarerHelp Diversity – resource development for diverse populations of end of life carers. - Di Saward
• The feasibility of ‘Beyond Cancer’, a multimodal support intervention for transitioning back to ‘good’ work following breast cancer - Georgina Lamb
• Geriatric Assessment (GA) in the Instagram era: adding photographs to electronic GA to enhance supportive care (ESC) of older adults with cancer  - Christopher Steer
• A systematic review of multi-modal prehabilitation in breast cancer   - Kellie Toohey
• The experiences of fear of cancer recurrence in ovarian cancer caregivers: a qualitative study - Kyra Webb
• Perceptions on diet and exercise behaviour of older adults with haematological cancer - Hattie H Wright
• Identifying symptom burden and unmet needs of women: Findings from a telehealth ovarian cancer support program - Patsy Yates
• Exercise behaviour in men with prostate cancer receiving ADT: a longitudinal mixed-methods exploration - Jasmine Yee
• Exercise motivation in men with prostate cancer receiving ADT: a theory-driven qualitative approach - Jasmine Yee
• Cost effectiveness of a 12-week virtual care enabled survivorship program - Karen Eaton
• Exploring the effects of cancer on the lives of gay and bisexual men - Colin D Ellis
• Evaluating the feasibility of a co-designed, online healthy living intervention for post-treatment cancer survivors: healthy living after cancer Online.   - Morgan Leske
• Designing for implementation: co-design of a paediatric oncology medicines database (ProCure) to support complex care provision for children with a hard-to-treat cancer - Carolyn G Mazariego
• Exercise during Chemotherapy for Recurrent Ovarian Cancer (ECHO-R): A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer - Carolina Sandler
• Gender and sexuality diverse (GSD) women’s experiences of cancer and cancer care - Sam Sperring
• High fibre diet significantly reduces astrocyte abundance in a mouse model of 5-FU induced neuroinflammation - Courtney Subramaniam
• Urokinase Plasminogen Activator Receptor and E-cadherin expression on tumour budding in gastroesophageal adenocarcinomas - Gary Tincknell
• Neoadjuvant and Adjuvant Pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): phase 3 KEYNOTE-689 - Elani Bowers
• Developing an intervention logic model for ‘Engage’: a novel, multi-disciplinary program for survivors of childhood cancer     - Joseph Elias
• Physical activity patterns during immunotherapy for stage III and IV melanoma - trial in progress - Sarah Marvin
• ASPiRATION: An Australian observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients. Protocol number TOGA 19/003. - Benjamin J Solomon
• Phase 3 study of Pembrolizumab as adjuvant treatment in high-risk locally advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) - Elani Bowers
• An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). - Danka Zebic

Join in Q&A via Slido code #2479762 or scan the QR code:

• He Oranga Pūkahukahu – an equity focused lung cancer screening research programme in Aotearoa New Zealand - Sue Crengle
• What matters most to rural and remote Australians when designing a potential lung cancer screening program? - Terri Byrne
• Lung Cancer Screening: Key Principles and Best Practice Approaches for Co-Design with Aboriginal and Torres Strait Islander Peoples - Gail Garvey
• “IFs and Butts”: addressing smoking cessation and incidental findings in lung cancer screening - Henry Marshall
• Early design and feasibility assessment of a potential Lung Cancer Screening Program in Australia - Vivienne Milch

• Addictions overview, tips for clinicians, brief advice - Amy Mullens
• E-cigarette use and addiction - Amelia Yazidjoglou
• Chronic cancer pain and contributors to the opioid epidemic   - Natasha Michael

• Achieving equitable access to cancer care and clinical trials in regional Australia: a networked approach to expand capacity and implement COSA teletrials model - Craig Underhill
• Regional Victorian Trials Alliance: linkages, innovation, special populations, equity (ReViTALISE) project: addressing disparity in regional populations. - Donna Long
• Victorian Comprehensive Cancer Centre Alliance- fast track innovations in regions with poor outcomes program: addressing geographical, cultural and rare cancer disparity - Kate Burbury
• Achieving equitable access to cancer care and clinical trials in regional Australia: Victorian teletrial collaborative: solving teletrial roadblocks - Anne Woollett

Followed by Panel Discussion

• FoRECAsT study: Predicting individualised risk of developing infertility in young breast cancer patients: an international multi-cohort study. - Zobaida Edib
• Association between skeletal muscle mass, nutrition status, and health-related quality of life at diagnosis of upper gastrointestinal cancer - Lauren Hanna
• Development and feasibility of an inpatient cancer-related sarcopenia pathway at a major cancer centre - Jenelle Loeliger
• AYA Can-Sleep: An evidence-based approach to the management of sleep difficulties in young people with cancer. - Andrew Murnane
• Role of compression sleeves in the prevention of breast cancer-related lymphoedema: A randomised controlled trial - Vincent Singh Paramanandam

• Immune response to COVID-19 vaccination in adults and children with cancer: results from the prospective SerOzNET study. - Amy Body
• Early and intensive nutrition delivered by telephone or mobile application on quality of life in people with upper gastrointestinal cancer: A process and mechanism of action for behaviour change evaluation - Kate Furness
• Future fertility in female cancer patients: births from frozen ovarian tissue - Ektoras Georgiou
• Machine learning-based prediction of adverse outcomes from malnutrition in people with cancer - Nicole Kiss
• Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment: a multi-centre, open-label, randomised controlled trial - Wee-Kheng Soo

Join us for a garden party on the Sky Terrace with lawn games, food carts and of course, dancing!